Publications by authors named "Martyna Filipska"

Claim this Profile
I
Impact of the mucosal milieu on antibody responses to allergens.
Andrea Cerutti, Martyna Filipska, Xavi Marcos Fa, Roser Tachó-Piñot

J Allergy Clin Immunol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiplex Analysis of CircRNAs from Plasma Extracellular Vesicle-Enriched Samples for the Detection of Early-Stage Non-Small Cell Lung Cancer.
Carlos Pedraz-Valdunciel, Stavros Giannoukakos, Ana Giménez-Capitán, Diogo Fortunato, Martyna Filipska

Pharmaceutics· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Digital multiplexed analysis of circular RNAs in FFPE and fresh non-small cell lung cancer specimens.
Carlos Pedraz-Valdunciel, Stavros Giannoukakos, Nicolas Potie, Ana Giménez-Capitán, Chung-Ying Huang, Martyna Filipska

Mol Oncol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutated circulating tumor DNA as a liquid biopsy in lung cancer detection and treatment.
Martyna Filipska, Rafael Rosell

Mol Oncol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Commentary: Safety and feasibility of CRISPR-edited T cells in patients with refractory non-small-cell lung cancer.
Rafael Rosell, Martyna Filipska, Imane Chaib, David Lligé, Fernando Laguia

Front Oncol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Osimertinib and pterostilbene in EGFR-mutation-positive non-small cell lung cancer (NSCLC).
Jillian Wilhelmina Paulina Bracht, Niki Karachaliou, Jordi Berenguer, Carlos Pedraz-Valdunciel, Martyna Filipska

Int J Biol Sci· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Osimertinib and dihydroartemisinin: a novel drug combination targeting head and neck squamous cell carcinoma.
Imane Chaib, Xueting Cai, David Llige, Mariacarmela Santarpia, Eloisa Jantus-Lewintre, Martyna Filipska

Ann Transl Med· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterising acquired resistance to erlotinib in non-small cell lung cancer patients.
Niki Karachaliou, Jordi Codony-Servat, Jillian Wilhelmina Paulina Bracht, Masaoki Ito, Martyna Filipska

Expert Rev Respir Med· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biological therapies in lung cancer treatment: using our immune system as an ally to defeat the malignancy.
Martyna Filipska, Carlos Pedraz-Valdunciel, Imane Chaib, Rafael Rosell

Expert Opin Biol Ther· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ALDH1-positive intratumoral stromal cells indicate differentiated epithelial-like phenotype and good prognosis in prostate cancer.
Paulina Nastały, Martyna Filipska, Colm Morrissey, Elke Eltze, Axel Semjonow

Transl Res· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MiR-192 and miR-662 enhance chemoresistance and invasiveness of squamous cell lung carcinoma.
Martyna Filipska, Marcin Skrzypski, Katarzyna Czetyrbok, Tomasz Stokowy, Grzegorz Stasiłojć

Lung Cancer· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
U937 variant cells as a model of apoptosis without cell disintegration.
Grzegorz Stasiłojć, Sandra Pinto, Roksana Wyszkowska, Magda Wejda, Ewa M Słomińska, Martyna Filipska

Cell Mol Biol Lett· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis